Bank Julius Baer & Co. Ltd, Zurich Exelixis, Inc. Transaction History

Bank Julius Baer & Co. Ltd, Zurich

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 09, 2022	SELL	$17.03 - $22.67 $6,812 - $9,068	-400 Closed	0 $0
Q4 2021 Feb 15, 2022	BUY	$15.84 - $21.88 $6,336 - $8,752	400 New	400 $7,000
Q2 2021 Jul 23, 2021	SELL	$17.95 - $25.56 $17,950 - $25,560	-1,000 Closed	0 $0
Q1 2021 May 10, 2021	BUY	$20.53 - $25.22 $20,530 - $25,220	1,000 New	1,000 $23,000

503

244M

2.54M

2.29M

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11.7B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

Get notified when there are updates to the investment portfolio of Bank Julius Baer & Co. Ltd, Zurich, based on Form 13F filings with the SEC.

Stay updated on Bank Julius Baer & Co. Ltd, Zurich with notifications on news.